Niloofar Deravi

Niloofar Deravi MD- Healthcare MBA student

E-mail: [email protected]

google scholar https: https://scholar.google.com/cita- tions?view_op=list_works&hl=en&hl=en&user=4F3ngpsAAAAJ&pagesize=80

Linked in: www.linkedin.com/in/Niloofarderavi

Education:

• Healthcare MBA student at Shahid Beheshti University of Medical Sciences, Tehran, Iran. |2021- present

• Medical student at Shahid Beheshti University of Medical Science, Tehran, Iran. (GPA=4/4) |2018- present

• Farzanegan 1 high school, NODET (National Organization for the Development of Ex- ceptional Talents), Tehran, Iran. (GPA=4/4) |2014-2018

• Farzanegan 1 middle school, NODET (National Organization for the Development of Ex- ceptional Talents), Tehran, Iran. (GPA=4/4) |2010-2013

Honors:

• Full scholarship to study Medicine at Shahid Beheshti University of Medical Sciences, Iran (2018)

• Ranked 439th (top 0.001%) in the 2018 National University Entrance Exam in the field of Experimental Sciences among 600,000 participants.

Memberships in professional societies

• 2019- present: Qualified as a member of National Foundation of Elites, Iran

• 2018- present: Qualified as a member of Shahid Beheshti University of Medical Sciences

Talents, Iran.

Skills:

• Software:



- professional experience with SPSS, GraphPad prism, and Microsoft office.

• Soft skills:

❖ Excellent team management:

- Leader of 27 research groups (as the corresponding author of narrative review articles);

- Published articles:

1. Hosseini P, Rahimi H, Najafabadi MM, Ghorbani A, Najafabadi SK, Faridzadeh A, Arabpour J, Khormali E, Deravi N. Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection. infection. 2021 Jan 1; 9:10. https://pubmed.ncbi.nlm.nih.gov/33818411/

❖ Professional public speaker:

- Among the top candidates of the best junior presenters in the third round of USERN Min-

iature Talk 2021.

- Host of 8 entrance ceremonies of the School of Medicine, Shahid Beheshti University of

Medical Sciences.

❖ Time management, never missing a deadline!

Experiences:

• 2021: Invited reviewer at “Frontiers in Immunology Journal (2019 IF=5.085)

• 2021: Invited reviewer at “Frontiers in Public Health” Journal (2019 IF=2.483)

• 2021: Mentor of Tehran University of Medical Sciences’ second research school (pro- posal writing school)

• 2021: Instructor of 3 research and methodology workshops of USERN, affiliated to Tehran University of Medical Sciences.



USERN, the official acronym of Universal Scientific Education and Research Net- work, is non-governmental, non-profit organization and network for peaceful non-mili- tary scientific executions and policy-making. USERN is organized exclusively for ad- vancement of authentic, ethical and professional scientific research and education and consequently advancement of science for non-military purposes and public good. Making international interdisciplinary scientific projects and providing a platform for more effec- tive communication among young researchers and experienced scientists, all over the world, is a head of USERN's schedule.



• 2020-2021 Instructor of 10 research and methodology workshops of Student Research Com- mittee, affiliated to Shahid Beheshti University of Medical Sciences

• 2020-2021: Junior M talk presenter at USERN Mtalk events 2020 and 2021.

• 2017-present: Member of Gabric Diabetes Education Association



The Gabric Diabetes Education Association is a non-profit, voluntary organization founded in 2006 with the aim of empowering the diabetic community. To date, Gabric has provided diabetes management training in more than 30 cities in the country for the dia- betic community, doctors, paramedics and the general public. Gabric is the only member of International Diabetes Federation (IDF) in Iran

Languages:



• Persian (Native)

• English (Advanced)

• German (Intermediate)

• Korean (Intermediate)

Publications:

1. Moazzeni SS, Arani RH, Deravi N, Hasheminia M, Khalili D, Azizi F, Hadaegh F. Weight change and risk of cardiovascular disease among adults with type 2 dia- betes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study. Cardiovascular diabetology. 2021 Dec;20(1):1-3

2. Aleebrahim-Dehkordi E, Deravi N, Yaghoobpoor S, Hooshyar D, Rafieian-Ko- paei M. The roles of vitamin D in increasing the body's immunity and reducing injuries due to viral infections: With an emphasis on its possible role in SARS- CoV-2 (COVID-19). Current pharmaceutical design. 2021 Jun 8.

3. Ghani S, Deravi N, Pirzadeh M, Rafiee B, Gatabi ZR, Bandehpour M, Yarian F. Antibody fragment and targeted colorectal cancer therapy: A global systematic review. Current Pharmaceutical Biotechnology. 2021 Aug 9

4. Lotfali E, Fattahi A, Sayyahfar S, Ghasemi R, Rabiei MM, Fathi M, Vakili K, Deravi N, Soheili A, Toreyhi H, Shirvani F. A Review on Molecular Mechanisms of Antifungal Resistance in Candida glabrata: Update and Recent Advances. Mi- crobial Drug Resistance. 2021 May 5

5. Hosseini P, Rahimi H, Najafabadi MM, Ghorbani A, Najafabadi SK, Faridzadeh A, Arabpour J, Khormali E, Deravi N. Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection. Acta Medica Indonesiana. 2021 Jan 1; 9:10.

6. Deravi N, Fathi M, Tabatabaeifar SN, Pooransari P, Ahmadi B, Shokoohi G, Yaghoobpoor S, Vakili K, Lotfali E, Ansari S. Azole Antifungal Resistance in Candida albicans and Candida glabrata Isolated from Vulvovaginal Candidiasis Patients. Archives of Clinical Infectious Diseases. 2021 Apr 30;16(2).

7. Ebrahimpour-Malekshah R, Amini A, Zare F, Mostafavi A, Davoody S, Deravi N, Rahmanian M, et al. Combined therapy of photobiomodulation and adipose- derived stem cells synergistically improve healing in an ischemic, infected and delayed healing wound model in rats with type 1 diabetes mellitus, BMJ Open Diabetes Research and Care 2020;8:e001033. doi: 10.1136/bmjdrc-2019- 001033

8. Fatemeh Moosaie, Reza Mohamadhosseinzadeh Davatgari, Fatemeh Dehghani Firouzabadi, Sadaf Esteghamati, Niloofar Deravi, Alipasha Meysamie, Pegah Khaloo, Manouchehr Nakhjavani, Alireza Esteghamati, Lipoprotein(a) and Apolipoproteins as Predictors for Diabetic Retinopathy and Its Severity in Adults With Type 2 Diabetes: A Case-Cohort Study, Canadian Journal of Diabe- tes,Volume 44, Issue 5, 2020,Pages 414-421, ISSN 1499-2671, https://doi.org/10.1016/j.jcjd.2020.01.007.

9. Fatemeh Moosaie, Neda Meftah, Niloofar Deravi, Kosar Abouhamzeh, Fatemeh Dehghani Firouzabadi, Pegah Khaloo, Mohammad Ali Mansournia, Seyede Mar- zie Fatemi Abhari, Manouchehr Nakhjavani, Alireza Esteghamati,Prevalence of diabetes-associated autoantibodies among patients presenting with type 2 diabetes and related metabolic differences, Primary Care Diabetes,2020

10. Aleebrahim-Dehkordi, Elahe, Faezeh Soveyzi, Niloofar Deravi, Zahra Rabbani, Amene Saghazadeh, and Nima Rezaei. "Human coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in children." Journal of Pediatric Nursing (2020).

11. Ghodsian, Sahar, Niloofar Taghipour, Niloofar Deravi, Hamed Behniafar, and Zohreh Lasjerdi. "Recent researches in effective antileishmanial herbal com- pounds: narrative review." Parasitology Research (2020): 1-18.

12. Ansari, S., Ahmadi, B., Hedayati, M.T., Nouripour‐Sisakht, S., Taghizadeh‐Ar- maki, M., Fathi, M., Deravi, N., Shokoohi, G.‐R. and Rezaei‐Matehkolaei, A. (2020), Investigation of in vitro antifungal susceptibility testing and genetic diver- sity of clinical isolates of Trichophyton benhamiae and Trichophyton eri- otrephon in Iran. Mycoses. https://doi.org/10.1111/myc.13210



13. Noori, Shokoofe, Mostafa Rezaei Tavirani, Niloofar Deravi, Mohammad Ismaiil Mahboobi Rabbani, and Afshin Zarghi. "Naringenin Enhances the Anti-Cancer Effect of Cyclophosphamide against MDA-MB-231 Breast Cancer Cells Via Tar- geting the STAT3 Signaling Pathway." Iranian Journal of Pharmaceutical Re- search (2020).

14. Niloofar Deravi, Mobina Fathi, Kimia Vakili, Shirin Yaghoobpoor, Marzieh Pir- zadeh, Melika Mokhtari, Tara Fazel, Elahe Ahsan, and Samad Ghaffari. "SARS- CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review." Reviews in cardiovascular medicine 21, no. 3 (2020): 385-397.

15. Deravi N, Yaghoobpoor S, Fathi M, Vakili K, Ahsan E, et al. 2019 Novel Coro- navirus Infection in Children and Infants: Where We Are and What We Know, Arch Clin Infect Dis. Online ahead of Print; In Press (In Press):e103785. doi: 10.5812/archcid.103785

16. Fathi, Mobina, Kimia Vakili, Niloofar Deravi, Shirin Yaghoobpoor, Elahe Ah- san, Melika Mokhtari, Maryam Moshfeghi, and Maryam Vaezjalali. "Coronavirus diseases and pregnancy: COVID-19, SARS, and MERS." Przeglad epidemiolog- iczny 74, no. 2 (2020): 276-289

17. Aleebrahim-Dehkordi E, Deravi N, Reyhanian A, Saberianpour S, Mokhtari M, Hasanpour-Dehkordi A. Chronic non-communicable diseases in the epidemic (COVID-19): Investigation of risk factors, control and care. Przegla̧ d epidemio- logiczny. 2020 Jan 1;74(3):449-56.

18. Kimia Vakili, Mobina Fathi, Shirin Yaghoobpoor, Niloofar Deravi, Soudeh Ghafouri-Fard, Recurrent IVF failure: Review of genetic factors, Gene Reports, Volume 20,2020,100685, ISSN 2452-0144, https://doi.org/10.1016/j.gen- rep.2020.100685.

19. Taghipour, Niloofar, Niloofar Deravi, and Mohsen Rahimi. "Chitosan-based Scaffolds, Suitable Structures for Wound Healing Dressing: A Short Review." Journal of" Regeneration, Reconstruction & Restoration"(Triple R) 5: e11-e11

20. Vakili, Kimia, Elahe Ahsan, Mobina Fathi, Niloofar Deravi, Shirin Yaghoobpoor, Melika Mokhtari, Tara Fazel et al. "A review on quarantine during COVID-19 outbreak: Lessons learned from previous epidemics." Social Determi- nants of Health 6: e13-e13.

21. Sarbandi H, Hosseini SM, Vakili K, Fathi M, Deravi N, Vaezjalali M. Hepatitis B Virus (Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus) among Hospital- ized Mentally Disabled Patients is not transmitted by their nurses or family mem- bers. ВИРУСОЛОГИИ. 2020;65(6):350.